Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Farmers Insurance
Citi
Cipla
Accenture

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 7,202,075

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,202,075
Title:Isolated protein having hydroxynitrile lyase activity
Abstract: New genes containing a DNA sequence coding for hydroxynitrile lyase, which genes can be prepared via a primer combination based on the DNA sequence of the 5\'-region of the mdl genes from the Prunus serotina and from Prunus amygdalus and/or a primer 2 based on the 3\'-region of the DNA sequences of one of the hydroxynitrile lyase isoenzymes from Prunus serotina or from Prunus amygdalus, subsequent amplification with a DNA polymerase using a DNA from organisms, containing genes coding for hydroxynitrile lyase, as templates and cloning, and also recombinant proteins which can be prepared in suitable host cells by heterologous expression of the DNA sequence of said HNL genes, and proteins and fusion proteins derived therefrom and use of said proteins for preparing (R)- or (S)-cyanohydrins.
Inventor(s): Schwab; Helmut (Graz, AT), Glieder; Anton (Gleisdorf, AT), Kratky; Christoph (Graz, AT), Dreveny; Ingrid (Graz, AT), Bona; Rodolfo (Graz, AT), Pochlauer; Peter (Linz, AT), Skranc; Wolfgang (Vienna, AT), Mayrhofer; Herbert (Engerwitzdorf, AT), Wirth; Irma (Enns, AT), Neuhofer; Rudolf (Engerwitzdorf, AT)
Assignee: DSM Fine Chemicals Austria NFG GmbH & Co KG (Linz, AT)
Application Number:10/940,954
Patent Claims:see list of patent claims

Details for Patent 7,202,075

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up DSM Fine Chemicals Austria NFG GmbH & Co KG (Linz, AT) 2021-01-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up DSM Fine Chemicals Austria NFG GmbH & Co KG (Linz, AT) 2021-01-16 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up DSM Fine Chemicals Austria NFG GmbH & Co KG (Linz, AT) 2021-01-16 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Teva
Argus Health
Citi
Mallinckrodt
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.